Avanos Medical, Inc. (NYSE: AVNS), a Georgia-based medical technology company involved in delivering medical device solutions, announced on Monday that it has named Indrani Franchini as a new independent member of the Avanos board of directors.
Franchini has worked as executive vice president and chief legal officer at Alnylam Pharmaceuticals, executive vice president and chief compliance officer at Alexion Pharmaceuticals, Inc, and has served in various roles in legal and compliance at Hess Corporation. She has also served for around 10 years at Pfizer in various positions, including supporting the global pharmaceutical business. She has also practiced law at Milbank LLP, where she served for six years working in the firm's New York and Tokyo offices.
Gary Blackford, Avanos board chair, said, 'We are excited to welcome Indrani Franchini to the Avanos board. Her experience with a broad range of global companies will be invaluable to Avanos as we pursue our vision of getting patients back to the things that matter.'
ColdVentures partners with Medco Sports Medicine to combat heat stroke
Median Technologies secures funding for eyonis Lung Cancer Screening software
MicroAire Surgical Instruments acquires NEOSYAD
UCB launches 320 mg/2 mL single-injection administration option for BIMZELX (bimekizumab-bkzx) in US
Concept Medical reports first patient enrolled in MagicTouch SCB trial in peripheral artery disease
Creo Medical Group plc launches robotic-guided lung ablation procedures in the UK
Revvity and Element Biosciences partner to enhance neonatal sequencing for IVD testing
Implantica publishes real-world data supporting RefluxStop efficacy
Abingdon Health subsidiary awarded GBP500,000 contract
NanoVibronix completes pilot phase of UroShield study at University of Michigan
Hologic acquires Gynesonics for USD350m
Inogen secures FDA clearance for SIMEOX 200 Airway Clearance Device
Microtech commences human clinical trial of microsensor platform for heart failure
Humacyte Global receives approval from FDA for Symvess
Defense Diagnostics launches DEFENT ONE All-In-One Fentanyl Detection Device in US